Health December 8, 2020
AstraZeneca-Oxford COVID-19 vaccine confirmed to have average 70% efficacy
The AstraZeneca-Oxford COVID-19 vaccine was confirmed by experts to have 70.4 percent average efficacy in an interim analysis of Phase…
Health December 8, 2020
The AstraZeneca-Oxford COVID-19 vaccine was confirmed by experts to have 70.4 percent average efficacy in an interim analysis of Phase…
By Dee Dulfo
America November 22, 2020
The clinical trial successes from pharmaceutical companies Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) on their COVID-19 vaccines gave…
By Dee Dulfo